Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis

Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis

Polypharmacy (intake of ≥5 drugs) is an important issue for patients with chronic diseases such as multiple sclerosis (MS). We aimed to assess the prevalence of polypharmacy with regard to the severity of anxiety/depression and to comorbidities. Therefore, 374 MS patients from two German neurologica...

Full description

Bibliographic Details
Main Authors: Julia Baldt, Niklas Frahm, Michael Hecker, Barbara Streckenbach, Silvan Elias Langhorst, Pegah Mashhadiakbar, Katja Burian, Janina Meißner, Felicita Heidler, Jörg Richter, Uwe Klaus Zettl
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Journal of Clinical Medicine
Subjects:
multiple sclerosis
depression
anxiety
polypharmacy
comorbidity
therapy switches
Online Access:https://www.mdpi.com/2077-0383/12/16/5379

Internet

https://www.mdpi.com/2077-0383/12/16/5379

Similar Items